Form 4 for LAB STANDARD BIOTOOLS INC.
Accepted 2024-07-02 00:00:00 ET · period of report 2024-06-28 · accession 0000950170-24-080745 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-07-02 | 2024-06-28 | LAB | Cox Troy | Dir | A - Grant | $0.00 | +43.1K | 161.8K | +36% | $0 |
| D | 2024-07-02 | 2024-06-28 | LAB | Cox Troy | Dir | A - Grant | $0.00 | +72.2K | 72.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-28 | A | A | 43,128 | $0.00 | 161,820 | D | — | — | (F1) Represents Restricted Stock Units ("RSUs") that vest in full on the earlier to occur of June 28, 2025 and one day prior to the date of the Company's next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting. (F2) The Reporting Person declined and forfeited the 79,412 RSUs previously granted to the Reporting Person on January 5, 2024 in connection with the transactions contemplated by the Agreement and Plan of Merger, dated October 4, 2023, by and among Standard BioTools Inc., Martis Merger Sub, Inc. and SomaLogic, Inc. |
| 2 | Derivative | Stock Option (Right to buy) | 2024-06-28 | A | A | 72,213 | $0.00 | 72,213 | D | $1.77 · — to 2034-06-28 | 72,213 Common Stock | (F3) The Option becomes exercisable in twelve equal monthly installments beginning on July 28, 2024, subject to the Reporting Person's continued service through the applicable vesting date. |